ICO
Closing Date:
Novel Therapeutic Approaches Targeting Microglia Biology for Neuroinflammatory Disorders
Astellas Pharma Inc. are an international pharmaceutical company seeking novel research programs targeting microglia biology for neuroinflammatory and/or neuroimmunological disorders. Astellas are interested in microglia biology with a focus on disease/pathophysiology-specific microglia. This could include aspects of the following, as well as other microglia‑specific disease traits:
- Lysosomal function
- Pyroptosis
- Autoimmune/inflammatory diseases
Target Diseases
Diseases of particular interest are neuroinflammatory disorders which have a strong/clear relevance...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile